Despite suffering from bottom-line indigestion relating to the acquisition of MJ GeneWorks in August, Bio-Rad Laboratories has negotiated a $200 million line of credit to go after even more acquisitions, the company said in a conference call last week after the release of its fourth-quarter financials.

In the quarter, which ended Dec. 31, the company sold $200 million of 6.125-percent senior subordinated notes due 2014 in a private offering.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.